Oriundo is a network of highly experienced healthcare CEOs here to help you find the right people to do business within Latin America. They are the only network of CEOs that provides a privileged level of corporate access into all 22 LatAm markets.
Whether you’re looking to access Latin America as a market, or a company within Latin America seeking International partners, Oriundo has the insights, network and critical local know-how to get you results.
Oriundo has deep and current local expertise and knowledge of Latin America’s players, economics and market dynamics. Oriundo will help you find the right partners to access Latin America’s valuable markets, saving you risk, time, legwork, expense and the inevitable “knocks”. And given Latin America is still the world’s fastest growing healthcare market worth over $76Bn annually, or 10% of the world market, it’s a place where it pays to have the right experience on your side.
It’s about finding the right chemistry, that’s what Oriundo does.
Contact
Address: Monte Athos 355-502. Lomas de Chapultepec. 11000 México DF. Mexico
Tel: +52 55 5520 1556
Website: http://oriundo.biz/
Ana Riquelme Francistain, executive director of the MedTech trade group Asociación Mexicana de Industrias Innovadoras de Dispositivos Médicos (AMID), details the trade and tax incentives that have favoured nearshoring from…
Four years ago, Daniel Del Conde left a career in multinational pharma to become the CEO of regional player Grupo Somar. He walks us through the company’s activities – private…
While the COVID-19 pandemic revealed vulnerabilities that sent many organizations looking for ways to bring supply chains closer to home, geopolitical tensions have also encouraged companies to avoid dependence on…
In a move to address medicine shortages Mexico’s outgoing president Andrés Manuel López Obrador last year launched a Super Pharmacy, or “Megafarmacia del Bienestar,” dubbed the largest medicine stockpile n…
The latest stories from Mexican pharma and healthcare, including Sanfer’s purchase of Colombia-based manufacturer Vitalis; Organon Mexico’s new business; the FDA’s warning to Glicerinas Industriales, and a look at the issues,…
Mexican voters will be heading to the polls next June for what will be the largest election process in the country’s history with concurrent state and federal elections. The election will…
The latest from Mexican pharma, including the distribution agreement between Dow and Azelis, Neuraxpharm’s new LatAm subsidiaries in Mexico and Brazil; Landsteiner Scientific’s restructure, and Merck’s plant expansion in Naucalpan.…
Latin America’s patient organisations are today playing a more important role than ever before in developing solutions to the continent’s most pressing healthcare challenges. Given the healthcare gaps that persist,…
Back in Latin America after several years in the US and Europe, Teva LatAm Head and Mexico GM Rodrigo Fernandez explains how the affiliate has adapted its strategy across the…
Mexico, with the second largest pharmaceutical market in Latin America, has a number of strong local pharma industry players. These companies, no longer focused solely on the domestic market, are…
María del Socorro España Lomelí, the executive director of Mexico’s National Association of Manufacturers of Medicines (ANAFAM), speaks to PharmaBoardroom about ANAFAM’s evolving relationship with the Mexican government and the…
Dagoberto Cortés Cervantes, president of Mexico’s National Association of Medicines Manufacturers (ANAFAM) and director of Grupo Sanfer/Hormona Mexico, outlines the expansion strategy that has led the manufacturing group to extend…
See our Cookie Privacy Policy Here
